Mineralys Therapeutics, Inc. (MLYS)
28.28
-0.76
(-2.63%)
USD |
NASDAQ |
Sep 03, 16:00
28.25
-0.02
(-0.09%)
After-Hours: 20:00
Mineralys Therapeutics Net Income (Annual) : -154.65M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -154.65M |
| December 31, 2024 | -177.81M |
| December 31, 2023 | -71.90M |
| Date | Value |
|---|---|
| December 31, 2022 | -29.80M |
| December 31, 2021 | -19.41M |
| December 31, 2020 | -3.426M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| MapLight Therapeutics, Inc. | -161.15M |
| Evommune, Inc. | -68.87M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |